Related Experiment Videos
Is epilepsy surgery possible in countries with limited resources?
1R. Madhavan Nayar Center for Comprehensive Epilepsy Care, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India.
Epilepsia
|August 30, 2000
Summary
Anterior temporal lobectomy (ATL) offers a cost-effective solution for medically refractory temporal lobe epilepsy (TLE). This epilepsy surgery leads to a 70% seizure-free rate and improved quality of life, proving more effective than ongoing medical treatment.
Area of Science:
- Neurosurgery
- Epileptology
- Health Economics
Background:
- Medically refractory temporal lobe epilepsy (TLE) poses significant challenges in management.
- Limited data exists on the cost-effectiveness of epilepsy surgery in developing countries.
Purpose of the Study:
- To evaluate the outcome and cost-effectiveness of anterior temporal lobectomy (ATL) for refractory TLE in South India.
- To compare ATL with continued medical management for TLE.
Main Methods:
- Retrospective analysis of 119 patients undergoing ATL and 71 controls with refractory TLE.
- Patient selection based on clinical, EEG, MRI, and video-EEG data.
- Outcome assessment included seizure freedom and antiepileptic drug reduction; cost analysis included direct medical expenses.
Main Results:
- ATL resulted in a 70% likelihood of seizure freedom and a 30% chance of complete drug withdrawal within 3 years.
- The one-time cost of ATL was approximately US$1,200, with total direct medical costs for TLE patients estimated at US$5,000.
- Seizure freedom improved employment prospects and quality of life.
Conclusions:
- Anterior temporal lobectomy is a cost-effective treatment option for refractory TLE compared to continued medical management.
- Epilepsy surgery is feasible and cost-effective even in developing nations.
- ATL significantly improves patient outcomes and quality of life.